Showing results (1531-1540 of 3,473) with videos related to
Sort By:
Pageof 348
Clinical Pharmacokinetics|January 1, 1985
Clinical pharmacokinetics of the retinoidsR W Lucek, W A ColburnClinical Pharmacokinetics|September 1, 1979
Biliary excretion of drugs in manD E Rollins, C D KlaassenClinical Pharmacokinetics|February 16, 1999
Clinical pharmacokinetics of sevofluraneM Behne, H J Wilke, S HarderClinical Pharmacokinetics|April 11, 2008
Retrospective population pharmacokinetic analysis of levetiracetam in children and adolescents with epilepsy: dosing recommendationsNathalie Toublanc, Maria Laura Sargentini-Maier, Brigitte Lacroix, et al.Clinical Pharmacokinetics|January 28, 2021
Population Pharmacokinetics of Docetaxel, Paclitaxel, Doxorubicin and Epirubicin in Pregnant Women with Cancer: A Study from the International Network of Cancer, Infertility and Pregnancy (INCIP)Julie M Janssen, Kristel Van Calsteren, Thomas P C Dorlo, et al.Clinical Pharmacokinetics|December 3, 2016
Effect of Activated Charcoal on Rivaroxaban Complex AbsorptionEdouard Ollier, Sophie Hodin, Julien Lanoiselée, et al.Clinical Pharmacokinetics|December 21, 2016
Population Pharmacokinetic Approach Applied to Positron Emission Tomography: Computed Tomography for Tumor Tissue Identification in Patients with GliomaPeggy Gandia, Cyril Jaudet, Hendrik Everaert, et al.Clinical Pharmacokinetics|December 22, 2016
Remarkable Pharmacokinetics of Monoclonal Antibodies: A Quest for an ExplanationJoannes A A Reijers, Matthijs Moerland, Jacobus BurggraafClinical Pharmacokinetics|December 13, 2016
Population Pharmacokinetics and Exploratory Pharmacodynamics of Lorazepam in Pediatric Status EpilepticusDaniel Gonzalez, James M Chamberlain, Jeffrey T Guptill, et al.Clinical Pharmacokinetics|October 27, 2016
Influence of FCGR3A-158V/F Genotype and Baseline CD20 Antigen Count on Target-Mediated Elimination of Rituximab in Patients with Chronic Lymphocytic Leukemia: A Study of FILO GroupMira Tout, Anne-Laure Gagez, Stéphane Leprêtre, et al.Pageof 348